Pharvaris N.V.
Pharvaris N.V. (PHVS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PHVS · as of Jun 8, 2026
Key Statistics
Explore Pharvaris N.V. Data
phvs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 91.7%
The PHVS analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $56.00, representing +77.27% upside from the current price of $31.59.
Competitors & Peers
phvs competitorsPHVS
ARDX
BCRX
IMNM
MAZE
NTLAStock Performance
Full HistoryAbout Pharvaris N.V.
Pharvaris N.V. is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and bringing to market treatments for uncommon diseases. Its primary pipeline asset, PHA121, is a sma…
what is pharvaris n.v. · phvs stock overview · pharvaris n.v. company profile · who is pharvaris n.v. ceo · phvs NASDAQ · pharvaris n.v. headquarters · pharvaris n.v. business segments
About Stock Overview & Key Data
Pharvaris N.V. (PHVS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 5, 2021. As of the latest trading session, PHVS stock price is $31.59, with a market capitalization of $2.2B. The stock has returned +73.70% over the past 12 months and +12.86% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Pharvaris N.V. stock is Buy, with an average 12-month price target of $56.00. In fiscal year 2025, Pharvaris N.V. reported revenue of — and net income of -$175.7M. For detailed data — including Pharvaris N.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pharvaris N.V. (PHVS) stock price is $31.59. The stock is traded on NASDAQ under the ticker symbol PHVS. The 52-week range is $15.91 – $33.33.